Aveanna Healthcare Holdings Inc. Common Stock (AVAH) Stock
Key stats
- Market cap
- $2.86B
- Price / Earnings ratio
- 10.5x
- EPS (TTM)
- $1.33
- Volume
- Loading
- 52-week high
- $14.71
- 52-week low
- $5.93
Source: third-party data provider, as of November 13, 2026
Compare with AVAH
Recent news

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
AVAH

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
AVAH

Implied Volatility Surging for Aveanna Healthcare Stock Options
Implied Volatility Surging for Aveanna Healthcare Stock Options
AVAH

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
AVAH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 50.43
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.01
- SMA 50
- $13.08
- Price above SMA 50
- EMA 50
- $12.73
- Price above EMA 50
- SMA 200
- $9.41
- Price above SMA 200
- EMA 200
- $10.22
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
AVAH

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
AVAH

Implied Volatility Surging for Aveanna Healthcare Stock Options
Implied Volatility Surging for Aveanna Healthcare Stock Options
AVAH

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
AVAH

Will Aveanna (AVAH) Beat Estimates Again in Its Next Earnings Report?
Will Aveanna (AVAH) Beat Estimates Again in Its Next Earnings Report?
AVAH

Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
AVAH

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
AVAH

5 Top-Ranked Stocks Likely to Deliver Earnings Beats
5 Top-Ranked Stocks Likely to Deliver Earnings Beats
AVAH

Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy
Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy
AVAH

Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
AVAH
News tone: automated (AI) classification of the article's content, not a price prediction.
About Aveanna Healthcare Holdings Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey S. Shaner | President, CEO & Director | 1973 |
| Mr. Rodney D. Windley | Executive Chairman | 1948 |
| Mr. Matthew Buckhalter | CFO & Principal Financial Officer | 1989 |
| Ms. Kristy Rohwedder | Chief Operating Officer | — |
| Mr. Ed Reisz | Chief Administrative Officer | 1959 |
| Ms. Deborah Stewart | Senior VP & Principal Accounting Officer | 1984 |
| Mr. Patrick A. Cunningham | Chief Compliance Officer | 1956 |
| Mr. Jerry Perchik | Chief Legal Officer & Secretary | 1958 |
| Mr. Shane Brinkerhoff | President of Home Health & Hospice | — |
| Ms. Rachel Witt | Chief Clinical Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 50.43
- MACD 12/26/9
- 0.16
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.01
- SMA 50
- $13.08
- Price above SMA 50
- EMA 50
- $12.73
- Price above EMA 50
- SMA 200
- $9.41
- Price above SMA 200
- EMA 200
- $10.22
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $13.00
- Average
- $14.71
- High
- $16.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -24.9 | +21.7 | ||||||||||
| 2022 | -26.4 | -1.1 | -33.5 | -14.6 | +5.1 | -24.4 | -10.5 | -12.5 | -13.8 | -9.2 | -49.3 | +2.6 |
| 2023 | +71.8 | +0.8 | -14.0 | +21.8 | +0.9 | +36.3 | +10.2 | -14.3 | -16.8 | +16.9 | +90.9 | -1.5 |
| 2024 | -16.7 | -2.1 | +4.2 | -13.8 | +17.0 | +7.0 | +69.1 | +35.8 | -2.8 | -6.2 | +26.6 | -21.9 |
| 2025 | +2.0 | -7.8 | +34.5 | -15.6 | +18.4 | -4.4 | -20.6 | +113.9 | +7.6 | +0.8 | -0.7 | -12.0 |
| 2026 | +4.0 | -11.6 | -13.3 | +4.0 | +8.5 | +28.5 | +6.0 | +39.6 | -7.8 | +5.9 | -0.2 |



